Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial

Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial

Abstract Background Interstitial lung diseases in children (chILD) are rare and consist of many different entities that affect the parenchyma of the lungs, leading to a chronic lung disease. The natural course of many of these diseases is connected with a high morbidity and significant mortality. Sy...

Full description

Bibliographic Details
Main Authors: Matthias Griese, Meike Köhler, Sabine Witt, Daniela Sebah, Matthias Kappler, Martin Wetzke, Nicolaus Schwerk, Nagehan Emiralioglu, Nural Kiper, Kai Kronfeld, Christian Ruckes, Hans Rock, Gisela Anthony, Elias Seidl
Format: Article
Language:English
Published: BMC 2020-04-01
Series:Trials
Subjects:
chILD
Interstitial lung disease
Hydroxychloroquine
Online Access:http://link.springer.com/article/10.1186/s13063-020-4188-4

Internet

http://link.springer.com/article/10.1186/s13063-020-4188-4

Similar Items